Showing 21 - 34 of 34 results
In part 1 of this two-part series, ANSTO scientists from across the organisation became film critics to review Christopher Nolan’s new movie, Oppenheimer, which explores the life of the director of the Manhattan Project to develop an atomic weapon.
ANSTO researchers have demonstrated longstanding expertise in the study of nuclear fuel and radioactive waste with two recent journal articles in a special issue of Frontiers of Chemistry.
ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.
INVAP, the Argentinian advanced nuclear technology company, who designed and constructed the Open Pool Lightwater Reactor (OPAL) for ANSTO to replace the HIFAR reactor is celebrating 50 years of operations with the visit of a group of INVAP executives to ANSTO to celebrate their achievements and discuss future collaborations.
Dr Linda Croton, a Research Fellow at Monash University, has been awarded the 2020 ANSTO Australian Synchrotron Stephen Wilkins Thesis medal for her outstanding work using synchrotron-based X-ray for brain imaging.
The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
See details of previously published customer updates from our Health products team.
Publications by ANSTO's National Deuteration Facility.
Read about an ANSTO scientist and their work to prepare for a school project or interview.
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.